RT Journal Article
SR Electronic
T1 Kanamycin
JF The British Edition of the Medical Letter on Drugs and
				Therapeutics
FD BMJ Publishing Group Ltd
SP 6
OP 8
DO 10.1136/dtb.s1-2.2.6
VO s1-2
IS 2
YR 1963
UL http://dtb.bmj.com/content/s1-2/2/6.abstract
AB Kanamycin sulphate (Kannasyn - Bayer) was introduced in Britain in 1959 mainly for use against resistant staphylococci. More recently the manufacturers have re-assessed the drug, and they now advocate it only for infections caused by Gram-negative organisms.